Published in Dig Dis Sci on July 01, 1981
Decreased sympathetic inhibition in gastroesophageal reflux disease. Clin Auton Res (2001) 1.49
Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut (1999) 0.96
Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis. Gut (2005) 0.89
Selective COX-2 inhibition is associated with decreased mucosal damage induced by acid and pepsin in rabbit esophagitis. Inflammation (2003) 0.85
Inflammatory mediators in the oesophagus. Gut (1994) 0.82
Role of platelet-activating factor in acid-induced esophageal mucosal injury. Dig Dis Sci (2007) 0.82
Oesophageal histology in long term users of non-steroidal anti-inflammatory drugs. J Clin Pathol (1994) 0.82
Prostaglandin E2 is the major arachidonic acid metabolite secreted by esophageal mucosal cells in rabbits. Inflammation (1997) 0.75
Classification of oesophageal motility abnormalities. Gut (2001) 4.86
Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis (1976) 3.71
The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol (1988) 3.53
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology (2001) 3.35
Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions. Dig Dis Sci (1987) 3.07
Hormonal control of gastroesophageal-sphincter strength. N Engl J Med (1970) 2.74
Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med (1982) 2.63
Activity of three murein hydrolases during the cell division cycle of Escherichia coli K-12 as measured in toluene-treated cells. J Bacteriol (1976) 2.49
Epithelial cell renewal in cultured rectal biopsies in ulcerative colitis. Gastroenterology (1973) 2.48
The accuracy of the physical examination in the diagnosis of suspected ascites. JAMA (1982) 2.35
Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Gastroenterology (1978) 2.21
Review article: an analysis of the efficacy, perforation rates and methods used in pneumatic dilation for achalasia. Aliment Pharmacol Ther (2011) 2.13
Evidence of gender differences in esophageal pain threshold. Am J Gastroenterol (1995) 2.09
Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther (2003) 2.05
Inhibitory effect of smoking on the lower esophageal sphincter. N Engl J Med (1971) 2.03
Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients. Ann Intern Med (1987) 2.02
Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci (1997) 1.99
Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol (1994) 1.97
Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci (1988) 1.91
Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol (1998) 1.90
Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology (1986) 1.87
Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy. Ann Intern Med (1989) 1.84
Diffuse esophageal spasm. A rare motility disorder not characterized by high-amplitude contractions. Dig Dis Sci (1991) 1.81
Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology (1972) 1.78
Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch Intern Med (1991) 1.77
Gastrointestinal epithelial renewal. Gastroenterology (1977) 1.74
Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci (1989) 1.72
Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol (1996) 1.72
Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg (2006) 1.66
Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol (1999) 1.65
Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther (1998) 1.65
Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg (1993) 1.64
Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol (1999) 1.63
Endoluminal ultrasonography of the distal esophagus in systemic sclerosis. Gastroenterology (1993) 1.60
Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol (2002) 1.60
Hormonal responses to graded surgical stress. Arch Intern Med (1987) 1.59
Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol (1996) 1.58
Diffuse esophageal spasm: a reappraisal. Ann Intern Med (1984) 1.57
Achalasia and diffuse esophageal spasm. Arch Intern Med (1976) 1.52
High amplitude, peristaltic esophageal contractions associated with chest pain and/or dysphagia. Gastroenterology (1979) 1.51
Gastroesophageal reflux in runners. Characteristics and treatment. Ann Intern Med (1990) 1.49
Organ culture of human rectal mucosa. Gastroenterology (1973) 1.49
Arsenic risk assessment. Environ Health Perspect (1994) 1.47
Inorganic arsenic: a need and an opportunity to improve risk assessment. Environ Health Perspect (1997) 1.47
Interspecies differences in susceptibility to perturbation of thyroid homeostasis: a case study with perchlorate. Regul Toxicol Pharmacol (2004) 1.45
An in vivo hamster bioassay to assess the toxicity of particulates for the lungs. Toxicol Appl Pharmacol (1982) 1.43
Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther (2001) 1.43
Effects of octreotide on esophageal visceral perception and cerebral evoked potentials induced by balloon distension. Am J Gastroenterol (1999) 1.43
Effect of dry swallows and wet swallows of different volumes on esophageal peristalsis. J Appl Physiol (1975) 1.42
Nadolol to treat aggression and psychiatric symptomatology in chronic psychiatric inpatients: a double-blind, placebo-controlled study. J Clin Psychiatry (1992) 1.42
Procedures for health risk assessment in Europe. Regul Toxicol Pharmacol (2001) 1.41
Pneumatic balloon dilation in achalasia: a prospective comparison of balloon distention time. Am J Gastroenterol (1998) 1.39
Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology. Arch Intern Med (1995) 1.39
Prospective manometric evaluation with pharmacologic provocation of patients with suspected esophageal motility dysfunction. Gastroenterology (1983) 1.39
Synergistic effects of cyclic AMP and nerve growth factor on neurite outgrowth and microtubule stability of PC12 cells. J Cell Biol (1985) 1.39
Experimental esophagitis in cats impairs lower esophageal sphincter pressure. Gastroenterology (1975) 1.38
Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol (1996) 1.34
Caffeine and the lower esophageal sphincter. Am J Dig Dis (1972) 1.33
Altered gastric emptying and secretion in primary anorexia nervosa. Gastroenterology (1979) 1.33
Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD. Gastrointest Endosc (2001) 1.33
Prospective randomized comparison of pneumatic dilatation technique in patients with idiopathic achalasia. Dig Dis Sci (1999) 1.32
Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol (1993) 1.31
A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol (1989) 1.28
Does early endoscopy benefit the patient with active upper gastrointestinal bleeding? Gastroenterology (1977) 1.27
Apparent complete lower esophageal sphincter relaxation in achalasia. Gastroenterology (1986) 1.25
Pneumatic dilatation is effective long-term treatment for achalasia. Dig Dis Sci (1998) 1.23
Respiratory complications of gastroesophageal reflux. Arch Intern Med (1985) 1.23
Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol (1977) 1.23
Evidence for diminished visceral pain with aging: studies using graded intraesophageal balloon distension. Am J Physiol (1997) 1.22
The spleen percussion sign. A useful diagnostic technique. Ann Intern Med (1967) 1.22
Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol (2001) 1.21
Esophageal radiography and manometry: correlation in 172 patients with dysphagia. AJR Am J Roentgenol (1987) 1.20
Gastric alkalinization. Effect on lower-esophageal-sphincter pressure and serum gastrin. N Engl J Med (1974) 1.20
Lower esophageal sphincter response to gastric alkalinization. A new mechanism for treatment of heartburn with antacids. Ann Intern Med (1971) 1.19
Imipramine decreases oesophageal pain perception in human male volunteers. Gut (1998) 1.19
Ambulatory 24-hour esophageal pH monitoring. Technology searching for a clinical application. J Clin Gastroenterol (1986) 1.18
Eastimation of liver size by percussion in normal individuals. Ann Intern Med (1969) 1.17
Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance. Aliment Pharmacol Ther (2006) 1.17
Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology (1998) 1.17
Vigorous achalasia: original description requires minor change. J Clin Gastroenterol (2001) 1.16
Effect of head position on the dynamics of the upper esophageal sphincter and pharynx. Dysphagia (1993) 1.16
The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci (1999) 1.16
Globus sensation is associated with hypertensive upper esophageal sphincter but not with gastroesophageal reflux. Dig Dis Sci (1998) 1.15
Fundoplication eliminates chronic cough due to non-acid reflux identified by impedance pH monitoring. Thorax (2005) 1.15
Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol (1996) 1.15
Pharyngeal and upper esophageal sphincter manometry in the evaluation of dysphagia. J Clin Gastroenterol (2001) 1.14
The effect of complement depletion on bacterial lipopolysaccharide (LPS)-induced hemodynamic and hematologic changes in the Rhesus monkey. Am J Pathol (1978) 1.14
Muscle anatomy of the human esophagus. J Clin Gastroenterol (1986) 1.14
Modern solid state computerized manometry of the pharyngoesophageal segment. Dysphagia (1993) 1.13
Basis for the observed fluctuation of carboxypeptidase II activity during the cell cycle in BUG 6, a temperature-sensitive division mutant of Escherichia coli. J Bacteriol (1977) 1.13
Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus. Gastroenterology (1987) 1.13
Relationship of radionuclide liquid bolus transport and esophageal manometry. J Lab Clin Med (1987) 1.13
Inhibition of the lower oesophageal sphincter by fat--a mechanism for fatty food intolerance. Gut (1973) 1.11
Evaluation of dysphagia: a careful history is crucial. Dysphagia (1987) 1.11
Stimulating research to improve the scientific basis of risk assessment. Toxicol Sci (1999) 1.11
Effects of parenteral hydrocortisone sodium succinate on epithelial renewal in hamster gastric mucosa. Dig Dis Sci (1988) 1.11
Assessing the relationship between environmental lead concentrations and adult blood lead levels. Risk Anal (1994) 1.11